Advances in genetic testing technologies are revolutionizing the abetalipoproteinemia monitoring systems market, enabling more accurate diagnosis, earlier intervention, and better long-term disease management. The identification of specific genetic mutations associated with abetalipoproteinemia has opened new avenues for monitoring disease progression and tailoring treatment strategies to...